Kellen E, et al. - Researchers intended to assess different strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer. This study was conducted on 35,354 women who did not participate in the Flemish cancer screening program were included. This randomized, controlled trial supported the efficacy of a self-sampling strategy to increase participation in the Flemish screening program. They suggested that self-sampling seemed particularly acceptable to postmenopausal non-responders.